drugset / Trial / NCT07469085
A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SV003 in Healthy Participants.
RandomizedSequentialDouble-blindTreatment
Summary
The objective of this clinical study is to evaluate the safety, tolerability, pharmacokinetic, and pharmacodynamic profiles of SV003 in healthy subjects.
Timeline
- Start
- 2026-04-04
- Primary completion
- 2026-10-31
- Completion
- 2027-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SV003 | Unknown | — | — |
Indications
No indication recorded.